当前位置:首页 - 行情中心 - 福元医药(601089) - 财务分析 - 现金流量表

福元医药

(601089)

  

流通市值:87.31亿  总市值:87.31亿
流通股本:4.80亿   总股本:4.80亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,664,304,246.52812,403,333.43,222,896,646.082,416,292,559.89
  收到的税费返还--721,226.14721,226.14
  收到其他与经营活动有关的现金25,566,346.6110,948,223.676,300,614.740,871,022.6
  经营活动现金流入小计1,689,870,593.13823,351,5573,299,918,486.922,457,884,808.63
  购买商品、接受劳务支付的现金267,793,384.54121,911,016.64612,332,336.02433,716,613.43
  支付给职工以及为职工支付的现金412,744,841.29245,534,514.04668,222,840.48512,862,659.8
  支付的各项税费183,798,043.4987,388,507.6350,726,265.68264,713,801.07
  支付其他与经营活动有关的现金568,700,537.46262,708,946.631,307,782,508.56932,420,005.06
  经营活动现金流出小计1,433,036,806.78717,542,984.912,939,063,950.742,143,713,079.36
  经营活动产生的现金流量净额256,833,786.35105,808,572.09360,854,536.18314,171,729.27
二、投资活动产生的现金流量:
  取得投资收益收到的现金12,078,428.225,500,178.0618,822,305.9716,642,246.78
  处置固定资产、无形资产和其他长期资产收回的现金净额461,43514,335885,027.71555,186.55
  收到的其他与投资活动有关的现金4,161,800,0001,995,800,0008,488,800,0007,290,000,000
  投资活动现金流入小计4,174,339,863.222,001,314,513.068,508,507,333.687,307,197,433.33
  购建固定资产、无形资产和其他长期资产支付的现金46,557,525.6228,694,361.99397,406,893.64346,089,558.6
  支付其他与投资活动有关的现金4,288,000,0002,110,000,0008,258,600,0006,109,800,000
  投资活动现金流出小计4,334,557,525.622,138,694,361.998,656,006,893.646,455,889,558.6
  投资活动产生的现金流量净额-160,217,662.4-137,379,848.93-147,499,559.96851,307,874.73
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金263,420.4-68,000-
  筹资活动现金流入平衡项目0-0-
  筹资活动现金流入小计263,420.4-68,000-
  偿还债务支付的现金--40,000,00040,000,000
  分配股利、利润或偿付利息支付的现金234,000,000-234,241,491.67234,241,491.67
  支付其他与筹资活动有关的现金8,831,339.536,857,274.9618,893,193.916,181,811.76
  筹资活动现金流出小计242,831,339.536,857,274.96293,134,685.57290,423,303.43
  筹资活动产生的现金流量净额-242,567,919.13-6,857,274.96-293,066,685.57-290,423,303.43
五、现金及现金等价物净增加额-145,951,795.18-38,428,551.8-79,711,709.35875,056,300.57
  加:期初现金及现金等价物余额634,048,094.3634,048,094.3713,759,803.65713,759,803.65
  期末现金及现金等价物余额488,096,299.12595,619,542.5634,048,094.31,588,816,104.22
补充资料:
  净利润187,708,519.97-471,263,535-
  资产减值准备6,101,874.66-16,491,237.75-
  固定资产和投资性房地产折旧64,225,843.11-99,789,270.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧64,225,843.11-99,789,270.17-
  无形资产摊销6,122,126.17-13,037,758.87-
  长期待摊费用摊销4,380,180.69-8,578,688.83-
  处置固定资产、无形资产和其他长期资产的损失-803,249.67--21,837.92-
  固定资产报废损失549,324.69-35,909.48-
  财务费用461,775.19-1,579,732.14-
  投资损失-11,394,743.61--17,756,892.4-
  递延所得税1,525,359.65-5,375,090.64-
  其中:递延所得税资产减少-729,475.68--1,083,400.81-
    递延所得税负债增加2,254,835.33-6,458,491.45-
  存货的减少-19,521,571.86--81,600,255.67-
  经营性应收项目的减少76,515,610.89--127,886,859.16-
  经营性应付项目的增加-64,049,101.6--46,564,461.39-
  其他-120,603.76--582,576.88-
  现金的期末余额488,096,299.12-634,048,094.3-
  减:现金的期初余额634,048,094.3-713,759,803.65-
  现金及现金等价物的净增加额-145,951,795.18--79,711,709.35-
公告日期2026-08-152026-04-252026-04-142025-10-30
审计意见(境内)标准无保留意见
TOP↑